Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate Cancer

This study has been completed.

Sponsor:

Collaborators:

Southwest Oncology Group

NCIC Clinical Trials Group

Cancer and Leukemia Group B

Eastern Cooperative Oncology Group

North Central Cancer Treatment Group

Radiation Therapy Oncology Group

Information provided by (Responsible Party):

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT00394511

First received: October 31, 2006

Last updated: February 8, 2013

Last verified: October 2006

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	December 2006 (Final data collection date for primary outcome measure)

Publications:

Swanson GP, Thompson IM, Tangem C, et al.: Phase III randomized study of adjuvant radiation therapy versus observation in patients with pathologic T3 prostate cancer (SWOG 8794). [Abstract] Int J Radiat Oncol Biol Phys 63 (Suppl 1): A-1, S1, 2005.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Thompson IM Jr, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA. 2006 Nov 15;296(19):2329-35.

To Top